NCT01163526View on ClinicalTrials.gov

Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies

TerminatedOBSERVATIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Neuroendocrine TumorsBrain (Nervous System) CancersColon/Rectal CancerColon CancerHepatobiliary CancersHepatocellular Carcinoma (Hepatoma)Liver
Interventions
PROCEDURE

CT perfusion

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

GE Healthcare
All Listed Sponsors
collaborator

Siemens Corporation, Corporate Technology

INDUSTRY

collaborator

GE Healthcare

INDUSTRY

lead

Stanford University

OTHER